Business
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting
Featured Scientific Session: "Evolution of Cytogenomic Technology: Real-World Applications of Optical Genome Mapping in the Laboratory", an accredited continuing medical education (CME) session, with a panel of experts presenting research on OGM's clinical and translational applications. Dr. Adam Smith (University of Toronto, Canada; currently at Labcorp, USA) will provide an overview of OGM’s evolution into an essential tool for hematological malignancy research and its role in research of pre-
About this update from Bionano Genomics, Inc.
[{"type":"image","alt":"Bionano Genomics","displaySize":"","headline":null,"caption":"Bionano Genomics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ylN8_Gs3_qAPxed5dOQIGw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1","width":300,"height":61}},"lazy":false},{"type":"text","content":"Featured Scientific Session: "Evolution of Cytogenomic Technology: Real-World Applications of Optical Genome Mapping in the Laboratory", an accredited continuing medical education (CME) session, with a panel of experts presenting research on OGM's clinical and translational applications.","length":302,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Dr. Adam Smith (University of Toronto, Canada; currently at Labcorp, USA) will provide an overview of OGM’s evolution into an essential tool for hematological malignancy research and its role in research of pre- and post-natal constitutional genetic disease.","length":258,"tagName":"p"}]},{"val":[{"type":"text","content":"Dr. Laila El-Khattabi (Sorbonne University Hospitals and the Brain Institute, Paris, France) will share results from the CHROMAPS project, a multi-institutional European collaboration utilizing OGM to evaluate structural variations and aneuploidies in constitutional and reproductive disorders.","length":294,"tagName":"p"}]},{"val":[{"type":"text","content":"Dr. Nikhil S. Sahajpal (Greenwood Genetic Center, USA) will present OGM findings from three clinical research cohorts, including neural tube defects (NTDs), undiagnosed rare disorders, and prenatal cases.","length":204,"tagName":"p"}]},{"val":[{"type":"text","content":"Dr. Rashmi Kanagal-Shamanna (The University of Texas, MD Anderson Cancer Center, USA) will showcase an integrated approach combining OGM and targeted NGS for hematologic malignancies, as well as OGM’s emerging role in quality control for CAR-T cell-based immunotherapies.","length":271,"tagName":"p"}]},{"val":[{"type":"text","content":"Two additional scientific posters featuring results from OGM applications in cancer and in postnatal genetic disorders will be presented at the conference","length":15...